TipRanks

Notifications

Analysts Have Conflicting Sentiments on These Healthcare Companies: Iovance Biotherapeutics (IOVA), Cellectis SA (CLLS) and Orthofix (OFIX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Iovance Biotherapeutics (IOVAResearch Report), Cellectis SA (CLLSResearch Report) and Orthofix (OFIXResearch Report).

Iovance Biotherapeutics (IOVA)

JMP Securities analyst Reni Benjamin reiterated a Buy rating on Iovance Biotherapeutics today and set a price target of $25.00. The company’s shares closed last Friday at $12.18.

According to TipRanks.com, Benjamin has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -5.2% and a 37.0% success rate. Benjamin covers the Healthcare sector, focusing on stocks such as Deciphera Pharmaceuticals, Spectrum Pharmaceuticals, and eFFECTOR Therapeutics.

Currently, the analyst consensus on Iovance Biotherapeutics is a Strong Buy with an average price target of $24.40, representing an 114.6% upside. In a report issued on August 4, Mizuho Securities also maintained a Buy rating on the stock with a $30.00 price target.

See today’s best-performing stocks on TipRanks >>

Cellectis SA (CLLS)

JMP Securities analyst Silvan Tuerkcan reiterated a Buy rating on Cellectis SA today and set a price target of $11.00. The company’s shares closed last Friday at $3.46, close to its 52-week low of $2.30.

According to TipRanks.com, Tuerkcan is a 3-star analyst with an average return of 2.9% and a 42.7% success rate. Tuerkcan covers the Healthcare sector, focusing on stocks such as Turning Point Therapeutics, Crispr Therapeutics AG, and Logicbio Therapeutics.

Cellectis SA has an analyst consensus of Moderate Buy, with a price target consensus of $7.50, a 134.4% upside from current levels. In a report issued on August 1, Robert W. Baird also maintained a Buy rating on the stock with a $10.00 price target.

Orthofix (OFIX)

JMP Securities analyst David Turkaly reiterated a Hold rating on Orthofix today. The company’s shares closed last Friday at $22.77, close to its 52-week low of $22.66.

According to TipRanks.com, Turkaly is a 4-star analyst with an average return of 6.4% and a 50.7% success rate. Turkaly covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Integra Lifesciences, and OrthoPediatrics.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Orthofix with a $31.00 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on IOVA:

Tags: